5,8,11-eicosatrienoic acid

5,8,11-eicosatrienoic acid is a lipid of Fatty Acyls (FA) class. 5,8,11-eicosatrienoic acid is associated with abnormalities such as Pulmonary Eosinophilia. The involved functions are known as antagonists, actin polymerization, release of sequestered calcium ion into cytoplasm, Neutrophil migration, function and Chemotaxis. 5,8,11-eicosatrienoic acid often locates in Cytoplasmic matrix and Back. The associated genes with 5,8,11-eicosatrienoic acid are Homologous Gene, IMPACT gene and ALOX12 gene. The related lipids are Fatty Acids and Eicosatrienoic Acid.

Cross Reference

Introduction

To understand associated biological information of 5,8,11-eicosatrienoic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 5,8,11-eicosatrienoic acid?

5,8,11-eicosatrienoic acid is suspected in Pulmonary Eosinophilia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 5,8,11-eicosatrienoic acid

MeSH term MeSH ID Detail
Atherosclerosis D050197 85 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Inflammatory Bowel Diseases D015212 9 associated lipids
Total 4

PubChem Associated disorders and diseases

What pathways are associated with 5,8,11-eicosatrienoic acid

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 5,8,11-eicosatrienoic acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 5,8,11-eicosatrienoic acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 5,8,11-eicosatrienoic acid?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 5,8,11-eicosatrienoic acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 5,8,11-eicosatrienoic acid?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 5,8,11-eicosatrienoic acid

Download all related citations
Per page 10 20 50 100 | Total 59
Authors Title Published Journal PubMed Link
pmid:
Kanda H et al. Inhibitors of arachidonic acid metabolism have variable effects on calcium signaling pathways. 2001 Am. J. Hypertens. pmid:11281236
Sakuradani E et al. Production of 5,8,11-eicosatrienoic acid by a delta5 and delta6 desaturation activity-enhanced mutant derived from a delta12 desaturation activity-defective mutant of Mortierella alpina 1S-4. 2002 Appl. Microbiol. Biotechnol. pmid:12436308
Fokkema MR et al. Assessment of essential fatty acid and omega3-fatty acid status by measurement of erythrocyte 20:3omega9 (Mead acid), 22:5omega6/20:4omega6 and 22:5omega6/22:6omega3. 2002 Prostaglandins Leukot. Essent. Fatty Acids pmid:12445496
Yoshida H et al. Beneficial effects of n-9 eicosatrienoic acid on experimental bowel lesions. 2003 Surg. Today pmid:12884098
MEAD JF and SLATON WH Metabolism of essential fatty acids. III. Isolation of 5,8,11-eicosatrienoic acid from fat-deficient rats. 1956 J. Biol. Chem. pmid:13319291
Ghebremeskel K and Leighfield M Infant brain lipids and diet. 1992 Lancet pmid:1357473
FULCO AJ and MEAD JF Metabolism of essential fatty acids. VIII. Origin of 5,8,11-eicosatrienoic acid in the fat-deficient rat. 1959 J. Biol. Chem. pmid:13654388
Heyd VL and Eynard AR Effects of eicosatrienoic acid (20:3 n-9, Mead's acid) on some promalignant-related properties of three human cancer cell lines. 2003 Prostaglandins Other Lipid Mediat. pmid:14518560
Nakano N et al. Effects of arachidonic acid analogs on FcepsilonRI-mediated activation of mast cells. 2005 Biochim. Biophys. Acta pmid:16403671
Coste TC et al. Influence of pancreatic status and sex on polyunsaturated fatty acid profiles in cystic fibrosis. 2008 Clin. Chem. pmid:18089657
Patel P et al. Structural requirements for activation of the 5-oxo-6E,8Z, 11Z,14Z-eicosatetraenoic acid (5-oxo-ETE) receptor: identification of a mead acid metabolite with potent agonist activity. 2008 J. Pharmacol. Exp. Ther. pmid:18292294
Strijbosch RA et al. Fish oil prevents essential fatty acid deficiency and enhances growth: clinical and biochemical implications. 2008 Metab. Clin. Exp. pmid:18442636
Hamazaki T et al. The depressive effects of 5,8,11-eicosatrienoic Acid (20:3n-9) on osteoblasts. 2009 Lipids pmid:18941818
Adkisson HD et al. Unique fatty acid composition of normal cartilage: discovery of high levels of n-9 eicosatrienoic acid and low levels of n-6 polyunsaturated fatty acids. 1991 FASEB J. pmid:2001795
van Goor SA et al. Mildly abnormal general movement quality in infants is associated with higher Mead acid and lower arachidonic acid and shows a U-shaped relation with the DHA/AA ratio. 2010 Prostaglandins Leukot. Essent. Fatty Acids pmid:20022733
Karaman IuK et al. [The role of modification of fatty acid composition of erythrocyte lipids in pathogenesis of arterial hypertension]. 2010 Kardiologiia pmid:20659041
Astarita G et al. Elevated stearoyl-CoA desaturase in brains of patients with Alzheimer's disease. 2011 PLoS ONE pmid:22046234
Hamazaki T et al. Inhibitory effect of 5,8,11-eicosatrienoic acid on angiogenesis. 2012 Prostaglandins Leukot. Essent. Fatty Acids pmid:22521862
Garcia MC et al. Chain elongation of polyunsaturated fatty acids by vascular endothelial cells: studies with arachidonate analogues. 1990 Lipids pmid:2345494